Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Plumeria Therapeutics Inc
Profile last edited on: 10/18/19      CAGE: 7WHA6      UEI: EMZ9GH4XKEJ4

Business Identifier: Non-opioid based pain management
Year Founded
2017
First Award
2018
Latest Award
2021
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

20 Marblehead Drive
West Windsor, NJ 08550
Location: Single
Congr. District: 12
County: Mercer

Public Profile

The organizing theme of those heading up Plumeria Therapeutics is to tackle development of precision therapeutics for pain management in neuro-inflammatory conditions. A clinical-stage biopharmaceutical firm, the principals are structured around non-opioid pain drugs to treat complex neuroinflammatory diseases with the current focus on pain management for diabetic neuropathy patients.

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$925,129
Phase II Dollars
$55,000
Total Awarded
$980,129

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2021 1 NIH $700,128
Project Title: Chemokine-receptor profiling for painful diabetic neuropathy in biological samples from human clinical trials
2018 1 NIH $280,001
Project Title: Chemokine-Receptor Expression Profiling in Biological Samples from Human Clinical Trials

Key People / Management

  Thomas P Richardson -- Co-Founder, President and CEO

  Lei Yu -- Co-Founder

Company News

There are no news available.